OLINVYK (oliceridine) injection is a new chemical entity indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate.
OLINVYK is not commercially available. Its controlled substance schedule is pending US Drug Enforcement Administration action.
Market Data 
Markets 
AI
